Virax Biolabs Group Ltd (VRAX)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current VRAX market cap is 11.02M. The company's latest EPS is USD -1.5516 and P/E is -1.62.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 100k | 124k | 0 | 9k | 156k |
| Operating Income | -651k | -644k | -1.73M | -5.73M | -6.5M |
| Net Income | -710k | -651k | -1.71M | -5.46M | -6.73M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 23k | 40k | 49k | 9.81M | 5.48M |
| Total Liabilities | 1.24M | 872k | 1.25M | 908k | 345k |
| Total Equity | -1.22M | -832k | -1.2M | 8.9M | 5.14M |
| Market Cap | 11.02M |
| Price to Earnings Ratio | -1.62 |
| Price to Sales Ratio | 70.19 |
| Price to Cash Ratio | 3.05 |
| Price to Book Ratio | 2.13 |
| Dividend Yield | - |
| Shares Outstanding | 4.34M |
| Average Volume (1 week) | 3.28M |
| Average Volume (1 Month) | 6.52M |
| 52 Week Change | -26.12% |
| 52 Week High | 8.9999 |
| 52 Week Low | 0.60 |
| Spread (Intraday) | 0.03 (1.18%) |
| Company Name | Virax Biolabs Group Ltd |
| Address |
30 broadwick street london oxon |
| Website | https://viraxbiolabs.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
